Skip to main content

Enliven Therapeutics, Inc. - Common Stock (NQ: ELVN )

24.54 -0.87 (-3.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form SC 13G/A
Source: SEC/Edgar
January 26, 2004
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form S-8 POS
Source: SEC/Edgar
July 28, 2003
Form SC 13D/A
Source: SEC/Edgar
July 27, 2003
Form 8-K
Source: SEC/Edgar
July 22, 2003
Form 15-12G
Source: SEC/Edgar
July 22, 2003
Form DEFA14A
Source: SEC/Edgar
July 02, 2003
Form DEFM14A
Source: SEC/Edgar
June 09, 2003
Form PREM14A
Source: SEC/Edgar
May 27, 2003
Form SC 13D
Source: SEC/Edgar
May 19, 2003
Form SC 13D/A
Source: SEC/Edgar
May 14, 2003
Form 8-K
Source: SEC/Edgar
May 08, 2003
Form SC 13G
Source: SEC/Edgar
May 06, 2003
Form DEF 14A
Source: SEC/Edgar
April 24, 2003
Form 10-K/A
Source: SEC/Edgar
April 24, 2003
Form SC 13G/A
Source: SEC/Edgar
February 13, 2003
Form SC 13G/A
Source: SEC/Edgar
January 20, 2003
Form SC 13G/A
Source: SEC/Edgar
January 07, 2003
Form 8-K
Source: SEC/Edgar
September 19, 2002
Form 8-K
Source: SEC/Edgar
July 21, 2002
Form DEF 14A
Source: SEC/Edgar
April 24, 2002
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.